View Cart (0 items)

Pharmaceutical

FDA approves H1N1 flu vaccines

September 16, 2009
The Food and Drug Administration has approved vaccines designed to protect against the H1N1 influenza virus, a key step before starting a vaccination campaign, reports the Wall Street Journal. Health
Read More

Lilly cutting 5,500 jobs, costs by $1 billion

September 15, 2009
Normal 0 0 1 147 839 6 1 1030 11.1282 0 0 0 According to Reuters, Eli Lilly and Co plans to cut 5,500 jobs, or 13.5 percent of
Read More

Facet Biotech calls Biogen offer too low

September 8, 2009
The Associated Press reports that Facet Biotech Corp. has turned down a $356 million buyout offer from drug development partner Biogen Idec Inc., saying it doesn''t properly value the company
Read More

Pfizer to pay record $2.3 billion penalty for drug promos

September 3, 2009
Federal prosecutors hit Pfizer Inc. with a record-breaking $2.3 billion in fines and called the world''s largest drugmaker a repeating corporate cheat for illegal drug promotions that plied doctors
Read More

Are US drug makers more innovative than their European counterparts?

August 26, 2009
Normal 0 0 1 159 908 7 1 1115 11.1282 0 0 0 The answer is yes. According to a 2006 paper published in the journal Health Affairs that
Read More

FDA reports health problems with stolen insulin

August 26, 2009
The Food and Drug Administration is warning consumers to avoid certain vials of insulin made by Novo Nordisk that were stolen earlier this year and may not be safe for
Read More

FDA drug chief is accused of conflict of interest

August 12, 2009
The Wall Street Journal reports that the inspector general of the Department of Health and Human Services is investigating a conflict-of-interest allegation involving the official in charge of drug approvals
Read More

Panel backs 12-year biotech drug shelter

August 3, 2009
Under a proposal adopted by a key House committee, Biotech drugs would be protected from competition from cheaper rivals for 12 years, reported by Reuters. The 47-11 vote in the
Read More

Medtronic will settle Abbott stent suit for $400 million

July 27, 2009
Medtronic Inc. has agreed to pay Abbott Laboratories $400 million to settle patent lawsuits related to the design of artery-opening stents, some of the most lucrative medical devices marketed by
Read More

Human Genome sells more anthrax drug to US government

July 22, 2009
The Associated Press reports that Human Genome Sciences Inc. announced that the U. S. government has placed an additional order for its inhaled anthrax treatment ABthrax for $151 million.
Read More